Molecular regulation of lymphangiogenesis in development and tumor microenvironment

Cancer Microenvironment

Volumn 5, Issue 3, 2012, Pages 249-260

  Li, Taotao ^a   Yang, Jianfeng ^a   Zhou, Quansheng ^a   He, Yulong ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

Lymphangiogenesis; Lymphatic endothelial cell; Tumor metastasis; Tumor microenvironment

Indexed keywords

ANGIOPOIETIN; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; PODOPLANIN; SECONDARY LYMPHOID TISSUE CHEMOKINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PROX1; TRANSCRIPTION FACTOR SOX18; UNCLASSIFIED DRUG; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 3;

ARTICLE; C1GALT1 GENE; CANCER GROWTH; CANCER INHIBITION; CELL COUNT; CELL DIFFERENTIATION; CELL INTERACTION; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSDIFFERENTIATION; ENDOTHELIUM CELL; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; HEMOSTASIS; HUMAN; LEUKOCYTE; LYMPH VESSEL; LYMPHANGIOGENESIS; MEGAKARYOCYTE; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; SMOOTH MUSCLE CELL; TUMOR CELL; TUMOR ESCAPE; TUMOR GROWTH; TUMOR INVASION; TUMOR MICROENVIRONMENT;

EID: 84864419163     PISSN: 18752292     EISSN: 18752284     Source Type: Journal    
DOI: 10.1007/s12307-012-0119-6     Document Type: Article

References (164)

1. Abtahian F, Guerriero A et al (2003) Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk. Science 299(5604):247–251.
2. Adams RH, Wilkinson GA et al (1999) Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev 13(3):295–306.
3. Albuquerque RJ, Hayashi T et al (2009) Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth. Nat Med 15(9):1023–1030.
4. Alitalo K (2011) The lymphatic vasculature in disease. Nat Med 17 (11):1371–1380.
5. Angeli V, Ginhoux F et al (2006) B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity 24(2):203–215.
6. Augustin HG, Young Koh G et al (2009) Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol 10(3):165–177.
7. Backhed F, Crawford PA et al (2007) Postnatal lymphatic partitioning from the blood vasculature in the small intestine requires fastinginduced adipose factor. Proc Natl Acad Sci USA 104(2):606–611.
8. Baldwin ME, Halford MM et al (2005) Vascular endothelial growth factor D is dispensable for development of the lymphatic system. Mol Cell Biol 25(6):2441–2449.
9. Baluk P, Tammela T et al (2005) Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J Clin Invest 115(2):247–257.
10. Baluk P, Fuxe J et al (2007) Functionally specialized junctions between endothelial cells of lymphatic vessels. J Exp Med 204(10):2349– 2362.
11. Baluk P, Yao LC et al (2009) TNF-alpha drives remodeling of blood vessels and lymphatics in sustained airway inflammation in mice. J Clin Invest 119(10):2954–2964.
12. Bazigou E, Xie S et al (2009) Integrin-alpha9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis. Dev Cell 17(2):175–186.
13. Beasley NJ, Prevo R et al (2002) Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res 62 (5):1315–1320.
14. Bertozzi CC, Schmaier AA et al (2010) Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling. Blood 116(4):661–670.
15. Bos FL, Caunt M et al (2011) CCBE1 is essential for mammalian lymphatic vascular development and enhances the lymphangiogenic effect of vascular endothelial growth factor-C in vivo. Circ Res 109 (5):486–491.
16. Bowles J, Schepers G et al (2000) Phylogeny of the SOX family of developmental transcription factors based on sequence and structural indicators. Dev Biol 227(2):239–255.
17. Carramolino L, Fuentes J et al (2010) Platelets play an essential role in separating the blood and lymphatic vasculatures during embryonic angiogenesis. Circ Res 106(7):1197–1201.
18. Caunt M, Mak J et al (2008) Blocking neuropilin-2 function inhibits tumor cell metastasis. Cancer Cell 13(4):331–342.
19. Chen L, Mupo A et al (2010) Tbx1 regulates Vegfr3 and is required for lymphatic vessel development. J Cell Biol 189(3):417–424.
20. Chen CY, Bertozzi C et al (2012) Blood flow reprograms lymphatic vessels to blood vessels. J Clin Invest 122(6):2006–2017.
21. Clavin NW, Avraham T et al (2008) TGF-beta1 is a negative regulator of lymphatic regeneration during wound repair. Am J Physiol Heart Circ Physiol 295(5):H2113–2127.
22. Condeelis J, Pollard JW (2006) Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124(2):263–266.
23. Cueni LN, Chen L et al (2010) Podoplanin-Fc reduces lymphatic vessel formation in vitro and in vivo and causes disseminated intravascular coagulation when transgenically expressed in the skin. Blood 116(20):4376–4384.
24. Dellinger M, Hunter R et al (2008) Defective remodeling and maturation of the lymphatic vasculature in Angiopoietin-2 deficient mice. Dev Biol 319(2):309–320.
25. Dummler B, Hemmings BA (2007) Physiological roles of PKB/Akt isoforms in development and disease. Biochem Soc Trans 35(Pt 2):231–235.
26. Dumont DJ, Jussila L et al (1998) Cardiovascular failure in mouse embryos deficient in VEGF receptor- 3. Science 282(5390):946–949.
27. Fagiani E, Lorentz P et al (2011) Angiopoietin-1 and −2 exert antagonistic functions in tumor angiogenesis, yet both induce lymphangiogenesis. Cancer Res 71(17):5717–5727.
28. Fischer C, Jonckx B et al (2007) Anti-PlGF inhibits growth of VEGF (R)-inhibitor-resistant tumors without affecting healthy vessels. Cell 131(3):463–475.
29. Flister MJ, Wilber A et al (2010) Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NFkappaB and Prox 1. Blood 115(2):418–429.
30. Forster R, Schubel A et al (1999) CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99(1):23–33.
31. Francois M, Caprini A et al (2008) Sox18 induces development of the lymphatic vasculature in mice. Nature 456(7222):643–647.
32. Fu J, Gerhardt H et al (2008) Endothelial cell O-glycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in mice. J Clin Invest 118(11):3725–3737.
33. Fukumura D, Duda DG et al (2010) Tumor microvasculature and microenvironment: novel insights through intravital imaging in pre-clinical models. Microcirculation 17(3):206–225.
34. Gale N, Thurston G et al (2002) Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by angiopoietin- 1. Dev Cell 3(3):411.
35. Geudens I, Herpers R et al (2010) Role of delta-like-4/Notch in the formation and wiring of the lymphatic network in zebrafish. Arterioscler Thromb Vasc Biol 30(9):1695–1702.
36. Gjini E, Hekking LH et al (2011) Zebrafish Tie-2 shares a redundant role with Tie-1 in heart development and regulates vessel integrity. Dis Model Mech 4(1):57–66.
37. Gunn MD, Tangemann K et al (1998) A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc Natl Acad Sci USA 95(1):258–263.
38. Hamada K, Oike Y et al (2000) VEGF-C signaling pathways through VEGFR-2 and VEGFR-3 in vasculoangiogenesis and hematopoiesis. Blood 96(12):3793–3800.
39. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674.
40. He Y, Kozaki K et al (2002) Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J Natl Cancer Inst 94 (11):819–825.
41. He Y, Karpanen T et al (2004a) Role of lymphangiogenic factors in tumor metastasis. Biochim Biophys Acta 1654(1):3–12.
42. He Y, Rajantie I et al (2004b) Preexisting lymphatic endothelium but not endothelial progenitor cells are essential for tumor lymphangiogenesis and lymphatic metastasis. Cancer Res 64(11):3737–3740.
43. He Y, Rajantie I et al (2005) Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res 65(11):4739–4746.
44. Hedrick JA, Zlotnik A (1997) Identification and characterization of a novel beta chemokine containing six conserved cysteines. J Immunol 159(4):1589–1593.
45. Hellstrom M, Kalen M et al (1999) Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 126(14):3047–3055.
46. Hidalgo A, Peired AJ et al (2007) Complete identification of E-selectin ligands on neutrophils reveals distinct functions of PSGL-1, ESL- 1, and CD 44. Immunity 26(4):477–489.
47. Hirakawa S, Kodama S et al (2005) VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 201(7):1089–1099.
48. Hogan BM, Bos FL et al (2009) Ccbe1 is required for embryonic lymphangiogenesis and venous sprouting. Nat Genet 41(4):396–398.
49. Holopainen T, Huang H et al (2009) Angiopoietin-1 overexpression modulates vascular endothelium to facilitate tumor cell dissemination and metastasis establishment. Cancer Res 69(11):4656– 4664.
50. Holopainen T, Saharinen P et al (2012) Effects of angiopoietin-2- blocking antibody on endothelial cell-cell junctions and lung metastasis. J Natl Cancer Inst 104(6):461–475.
51. Hong YK, Harvey N et al (2002) Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate. Dev Dyn 225 (3):351–357.
52. Horiguchi A, Ito K et al (2008) Intratumoral lymphatics and lymphatic invasion are associated with tumor aggressiveness and poor prognosis in renal cell carcinoma. Urology 71(5):928–932.
53. Hromas R, Kim CH et al (1997) Isolation and characterization of Exodus-2, a novel C-C chemokine with a unique 37-amino acid carboxyl-terminal extension. J Immunol 159(6):2554–2558.
54. Hu B, Guo P et al (2003) Angiopoietin-2 induces human glioma invasion through the activation of matrix metalloprotease- 2. Proc Natl Acad Sci USA 100(15):8904–8909.
55. Hu B, Jarzynka MJ et al (2006) Angiopoietin 2 induces glioma cell invasion by stimulating matrix metalloprotease 2 expression through the alphavbeta1 integrin and focal adhesion kinase signaling pathway. Cancer Res 66(2):775–783.
56. Ichise H, Ichise T et al (2009) Phospholipase Cgamma2 is necessary for separation of blood and lymphatic vasculature in mice. Development 136(2):191–195.
57. Imanishi Y, Hu B et al (2007) Angiopoietin-2 stimulates breast cancer metastasis through the alpha(5)beta(1) integrin-mediated pathway. Cancer Res 67(9):4254–4263.
58. Imanishi Y, Hu B et al (2011) Angiopoietin-2, an angiogenic regulator, promotes initial growth and survival of breast cancer metastases to the lung through the integrin-linked kinase (ILK)-AKT-B cell lymphoma 2 (Bcl-2) pathway. J Biol Chem 286(33):29249–29260.
59. Irigoyen M, Anso E et al (2007) Hypoxia alters the adhesive properties of lymphatic endothelial cells. A transcriptional and functional study. Biochim Biophys Acta 1773(6):880–890.
60. Irjala H, Johansson EL et al (2001) Mannose receptor is a novel ligand for L-selectin and mediates lymphocyte binding to lymphatic endothelium. J Exp Med 194(8):1033–1042.
61. Issa A, Le TX et al (2009) Vascular endothelial growth factor-C and CC chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype. Cancer Res 69(1):349–357.
62. Iwata C, Kano MR et al (2007) Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via reduction of lymphangiogenesis. Cancer Res 67(21):10181–10189.
63. Jiang S, Bailey AS et al (2008) Hematopoietic stem cells contribute to lymphatic endothelium. PLoS One 3(11):e3812.
64. Johnson LA, Jackson DG (2008) Cell traffic and the lymphatic endothelium. Ann N Y Acad Sci 1131:119–133.
65. Johnson LA, Clasper S et al (2006) An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium. J Exp Med 203(12):2763–2777.
66. Jurisic G, Maby-El Hajjami H et al (2012) “An Unexpected Role of Semaphorin3A/Neuropilin-1 Signaling in Lymphatic Vessel Maturation and Valve Formation”. Circ Res 2012 Jun 20. doi:10.1161/CIRCRESAHA.112.269399.
67. Kabashima K, Shiraishi N et al (2007) CXCL12-CXCR4 engagement is required for migration of cutaneous dendritic cells. Am J Pathol 171(4):1249–1257.
68. Kaipainen A, Korhonen J et al (1995) Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 92(8):3566–3570.
69. Kanady JD, Dellinger MT et al (2011) Connexin37 and Connexin43 deficiencies in mice disrupt lymphatic valve development and result in lymphatic disorders including lymphedema and chylothorax. Dev Biol 354(2):253–266.
70. Kang S, Lee SP et al (2009) Toll-like receptor 4 in lymphatic endothelial cells contributes to LPS-induced lymphangiogenesis by chemotactic recruitment of macrophages. Blood 113(11):2605–2613.
71. Karkkainen MJ, Ferrell RE et al (2000) Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat Genet 25 (2):153–159.
72. Karkkainen MJ, Saaristo A et al (2001) A model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci USA 98 (22):12677–12682.
73. Karkkainen MJ, Haiko P et al (2004) Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 5(1):74–80.
74. Karpanen T, Egeblad M et al (2001) Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res 61(5):1786–1790.
75. Karpanen T, Heckman CA et al (2006) Functional interaction of VEGF-C and VEGF-D with neuropilin receptors. FASEB J 20 (9):1462–1472.
76. Kataru RP, Jung K et al (2009) Critical role of CD11b+macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution. Blood 113(22):5650–5659.
77. Kataru RP, Kim H et al (2011) T lymphocytes negatively regulate lymph node lymphatic vessel formation. Immunity 34(1):96–107.
78. Kazenwadel J, Secker GA et al (2012) “Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature”. Blood 119(5):1283–1291.
79. Kerjaschki D (2005) The crucial role of macrophages in lymphangiogenesis. J Clin Invest 115(9):2316–2319.
80. Kerjaschki D, Regele HM et al (2004) Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J Am Soc Nephrol 15(3):603–612.
81. Kim I, Kim HG et al (2000) Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3′-Kinase/Akt signal transduction pathway. Circ Res 86(1):24–29.
82. Kim H, Nguyen VP et al (2010a) Embryonic vascular endothelial cells are malleable to reprogramming via Prox1 to a lymphatic gene signature. BMC Dev Biol 10:72.
83. Kim M, Koh YJ et al (2010b) CXCR4 signaling regulates metastasis of chemoresistant melanoma cells by a lymphatic metastatic niche. Cancer Res 70(24):10411–10421.
84. Kim H, Kataru RP et al (2012) Regulation and implications of inflammatory lymphangiogenesis. Trends Immunol 33(7):350–356.
85. Kozaki K, Miyaishi O et al (2000) Establishment and characterization of a human lung cancer cell line NCI- H460-LNM35 with consistent lymphogenous metastasis via both subcutaneous and orthotopic propagation. Cancer Res 60(9):2535–2540.
86. Kozaki K, Koshikawa K et al (2001) Multi-faceted analyses of a highly metastatic human lung cancer cell line NCI-H460-LNM35 suggest mimicry of inflammatory cells in metastasis. Oncogene 20 (31):4228–4234.
87. Kraizer Y, Mawasi N et al (2001) Vascular endothelial growth factor and angiopoietin in liver regeneration. Biochem Biophys Res Commun 287(1):209–215.
88. Krishnan J, Kirkin V et al (2003) Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats. Cancer Res 63(3):713–722.
89. Kumar SR, Singh J et al (2006) Receptor tyrosine kinase EphB4 is a survival factor in breast cancer. Am J Pathol 169(1):279–293.
90. Lapinski PE, Kwon S et al (2012) “RASA1 maintains the lymphatic vasculature in a quiescent functional state in mice”. J Clin Invest 122(2):733–747.
91. Ledgerwood LG, Lal G et al (2008) The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics. Nat Immunol 9(1):42–53.
92. Lee K, Park do J et al (2010) Increased intratumoral lymphatic vessel density correlates with lymph node metastasis in early gastric carcinoma. Ann Surg Oncol 17(1):73–80.
93. Lin FJ, Chen X et al (2010) Direct transcriptional regulation of neuropilin-2 by COUP-TFII modulates multiple steps in murine lymphatic vessel development. J Clin Invest 120(5):1694–1707.
94. Luther SA, Tang HL et al (2000) Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse. Proc Natl Acad Sci USA 97 (23):12694–12699.
95. Makinen T, Jussila L et al (2001) Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor- 3. Nat Med 7(2):199–205.
96. Makinen T, Adams RH et al (2005) PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes Dev 19(3):397–410.
97. Mantovani A, Allavena P et al (2008) Cancer-related inflammation. Nature 454(7203):436–444.
98. Maruyama K, Ii M et al (2005) Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest 115(9):2363–2372.
99. Miteva DO, Rutkowski JM et al (2010) Transmural flow modulates cell and fluid transport functions of lymphatic endothelium. Circ Res 106(5):920–931.
100. Morisada T, Oike, Y et al (2005) “Angiopoietin-1 promotes LYVE-1- positive lymphatic vessel formation”. Blood 105(12):4649–4656
101. Mouta-Bellum C, Kirov A et al (2009) Organ-specific lymphangiectasia, arrested lymphatic sprouting, and maturation defects resulting from gene-targeting of the PI3K regulatory isoforms p85alpha, p55alpha, and p50alpha. Dev Dyn 238(10):2670–2679.
102. Muller A, Homey B et al (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410(6824):50–56.
103. Nagira M, Imai T et al (1997) Molecular cloning of a novel human CC chemokine secondary lymphoid-tissue chemokine that is a potent chemoattractant for lymphocytes and mapped to chromosome 9p 13. J Biol Chem 272(31):19518–19524.
104. Niessen K, Zhang G et al (2010) ALK1 signaling regulates early postnatal lymphatic vessel development. Blood 115(8):1654–1661.
105. Niessen K, Zhang G et al (2011) The Notch1-Dll4 signaling pathway regulates mouse postnatal lymphatic development. Blood 118 (7):1989–1997.
106. Nilsson I, Bahram F et al (2010) VEGF receptor 2/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts. EMBO J 29(8):1377–1388.
107. Norrmen C, Ivanov KI et al (2009) FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc 1. J Cell Biol 185(3):439–457.
108. Norrmen C, Tammela T et al (2011) Biological basis of therapeutic lymphangiogenesis. Circulation 123(12):1335–1351.
109. Oka M, Iwata C et al (2008) Inhibition of endogenous TGF-beta signaling enhances lymphangiogenesis. Blood 111(9):4571–4579.
110. Okazaki T, Ni A et al (2009) alpha5beta1 Integrin blockade inhibits lymphangiogenesis in airway inflammation. Am J Pathol 174 (6): 2378–2387.
111. Oliver G, Detmar M (2002) The rediscovery of the lymphatic system: old and new insights into the development and biological function of the lymphatic vasculature. Genes Dev 16(7):773–783.
112. Paavonen K, Puolakkainen P et al (2000) Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing. Am J Pathol 156(5):1499–1504.
113. Padera TP, Kadambi A et al (2002) Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 296 (5574):1883–1886.
114. Pajusola K, Aprelikova O et al (1992) FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines [published erratum appears in Cancer Res 1993 Aug 15;53(16):3845]. Cancer Res 52(20):5738–5743.
115. Papapetropoulos A, Fulton D et al (2000) Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway. J Biol Chem 275(13):9102–9105
116. Pennisi D, Gardner J et al (2000) Mutations in Sox18 underlie cardiovascular and hair follicle defects in ragged mice. Nat Genet 24(4):434–437.
117. Petrova TV, Makinen T et al (2002) Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO J 21(17):4593–4599.
118. Petrova TV, Karpanen T et al (2004) Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat Med 10(9):974–981.
119. Pollard JW (2004) Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4(1):71–78.
120. Prevo R, Banerji S et al (2004) Rapid plasma membrane-endosomal trafficking of the lymph node sinus and high endothelial venule scavenger receptor/homing receptor stabilin-1 (FEEL-1/CLEVER- 1). J Biol Chem 279(50):52580–52592.
121. Rinderknecht M, Detmar M (2008) Tumor lymphangiogenesis and melanoma metastasis. J Cell Physiol 216(2):347–354.
122. Ristimaki A, Narko K et al (1998) Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C. J Biol Chem 273(14):8413–8418.
123. Roberts N, Kloos B et al (2006) Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR- 2. Cancer Res 66(5):2650–2657.
124. Ruddell A, Kelly-Spratt KS et al (2008) p19/Arf and p53 suppress sentinel lymph node lymphangiogenesis and carcinoma metastasis. Oncogene 27 (22): 3145–3155.
125. Saban MR, Memet S et al (2004) Visualization of lymphatic vessels through NF-kappaB activity. Blood 104(10):3228–3230.
126. Sabine A, Agalarov Y et al (2012) “Mechanotransduction, PROX1, and FOXC2 cooperate to control connexin37 and calcineurin during lymphatic-valve formation”. Dev Cell 22(2):430–444.
127. Saharinen P, Helotera H et al (2010) Claudin-like protein 24 interacts with the VEGFR-2 and VEGFR-3 pathways and regulates lymphatic vessel development. Genes Dev 24(9):875–880.
128. Salmi M, Koskinen K et al (2004) CLEVER-1 mediates lymphocyte transmigration through vascular and lymphatic endothelium. Blood 104(13):3849–3857.
129. Schepers GE, Teasdale RD et al (2002) Twenty pairs of sox: extent, homology, and nomenclature of the mouse and human sox transcription factor gene families. Dev Cell 3(2):167–170
130. Schmid-Schonbein GW (1990) Microlymphatics and lymph flow. Physiol Rev 70(4):987–1028.
131. Schoppmann SF, Birner P et al (2001) “Lymphatic microvessel density and lymphovascular invasion assessed by anti-podoplanin immunostaining in human breast cancer.”. Anticancer Res 21(4A):2351–2355.
132. Schulz P, Fischer C et al (2011) Angiopoietin-2 drives lymphatic metastasis of pancreatic cancer. FASEB J 25(10):3325–3335.
133. Schwab SR, Cyster JG (2007) Finding a way out: lymphocyte egress from lymphoid organs. Nat Immunol 8(12):1295–1301.
134. Shields JD, Kourtis IC et al (2010) Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL 21. Science 328(5979):749–752.
135. Shimoda H, Bernas MJ et al (2007) Abnormal recruitment of periendothelial cells to lymphatic capillaries in digestive organs of angiopoietin-2-deficient mice. Cell Tissue Res 328(2):329–337.
136. Shiojima I, Walsh K (2006) Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway. Genes Dev 20 (24):3347–3365.
137. Shrestha B, Hashiguchi T et al (2010) B cell-derived vascular endothelial growth factor A promotes lymphangiogenesis and high endothelial venule expansion in lymph nodes. J Immunol 184 (9):4819–4826.
138. Srinivasan RS, Geng X et al (2010) The nuclear hormone receptor Coup- TFII is required for the initiation and early maintenance of Prox1 expression in lymphatic endothelial cells. Genes Dev 24(7):696–707.
139. Stacker SA, Baldwin ME et al (2002) The role of tumor lymphangiogenesis in metastatic spread. FASEB J 16(9):922–934.
140. Straume O, Jackson DG et al (2003) Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma. Clin Cancer Res 9(1):250–256.
141. Suri C, Jones PF et al (1996) Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87 (7):1171–1180
142. Suzuki-Inoue K, Inoue O et al (2010) “Essential in vivo roles of the Ctype lectin receptor CLEC-2: embryonic/neonatal lethality of CLEC-2-deficient mice by blood/lymphatic misconnections and impaired thrombus formation of CLEC-2-deficient platelets”. J Biol Chem 285(32):24494–24507.
143. Swartz MA, Kaipainen A et al (1999) Mechanics of interstitiallymphatic fluid transport: theoretical foundation and experimental validation. J Biomech 32(12):1297–1307.
144. Tammela T, Saaristo A et al (2005) Angiopoietin-1 promotes lymphatic sprouting and hyperplasia. Blood 105(12):4642–4648.
145. Tammela T, Zarkada G et al (2008) Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature 454 (7204):656–660.
146. Taniguchi K, Kohno R et al (2007) Spreds are essential for embryonic lymphangiogenesis by regulating vascular endothelial growth factor receptor 3 signaling. Mol Cell Biol 27 (12):4541–4550.
147. Uhrin P, Zaujec J et al (2010) “Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation”. Blood 115(19):3997–4005
148. Van den Eynden GG, Vandenberghe MK et al (2007) Increased sentinel lymph node lymphangiogenesis is associated with nonsentinel axillary lymph node involvement in breast cancer patients with a positive sentinel node. Clin Cancer Res 13(18 Pt 1): 5391–5397.
149. Wang Y, Oliver G (2010) Current views on the function of the lymphatic vasculature in health and disease. Genes Dev 24(19):2115–2126.
150. Wang HU, Chen ZF et al (1998) Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B 4. Cell 93(5):741–753.
151. Wang Y, Nakayama M et al (2010) Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature 465(7297):483–486.
152. Wegner M (1999) From head to toes: the multiple facets of Sox proteins. Nucleic Acids Res 27(6):1409–1420.
153. Wigle JT, Oliver G (1999) Prox1 function is required for the development of the murine lymphatic system. Cell 98(6):769–778.
154. Wigle JT, Chowdhury K et al (1999) Prox1 function is crucial for mouse lens-fibre elongation. Nat Genet 21(3):318–322.
155. Wigle JT, Harvey N et al (2002) An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J 21 (7):1505–1513.
156. Wiley HE, Gonzalez EB et al (2001) Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. J Natl Cancer Inst 93(21):1638–1643.
157. Willis RA (1973) The spread of tumours in the human body. Butterworths, London
158. Wyble CW, Hynes KL et al (1997) TNF-alpha and IL-1 upregulate membrane-bound and soluble E-selectin through a common pathway. J Surg Res 73(2):107–112.
159. Xu Y, Yuan L et al (2010) Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR 3. J Cell Biol 188 (1):115–130.
160. Yuan L, Moyon D et al (2002) Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development 129(20):4797–4806.
161. Zhang X, Groopman JE et al (2005) Extracellular matrix regulates endothelial functions through interaction of VEGFR-3 and integrin alpha5beta 1. J Cell Physiol 202(1):205–214.
162. Zhang L, Zhou F et al (2010) VEGFR-3 ligand-binding and kinase activity are required for lymphangiogenesis but not for angiogenesis. Cell Res 20(12):1319–1331.
163. Zhou F, Chang Z et al (2010) Akt/Protein kinase B is required for lymphatic network formation, remodeling, and valve development. Am J Pathol 177(4):2124–2133.
164. Zumsteg A, Baeriswyl V et al (2009) Myeloid cells contribute to tumor lymphangiogenesis. PLoS One 4(9):e7067